JPS6341887B2 - - Google Patents

Info

Publication number
JPS6341887B2
JPS6341887B2 JP53132488A JP13248878A JPS6341887B2 JP S6341887 B2 JPS6341887 B2 JP S6341887B2 JP 53132488 A JP53132488 A JP 53132488A JP 13248878 A JP13248878 A JP 13248878A JP S6341887 B2 JPS6341887 B2 JP S6341887B2
Authority
JP
Japan
Prior art keywords
tocol
derivative
steroids
steroid
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53132488A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5480404A (en
Inventor
Koruneriusu Ranmeruto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of JPS5480404A publication Critical patent/JPS5480404A/ja
Publication of JPS6341887B2 publication Critical patent/JPS6341887B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
JP13248878A 1977-10-29 1978-10-27 High concentrated pharmaceutical preparation of steroid and production thereof Granted JPS5480404A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7711916A NL7711916A (nl) 1977-10-29 1977-10-29 Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.

Publications (2)

Publication Number Publication Date
JPS5480404A JPS5480404A (en) 1979-06-27
JPS6341887B2 true JPS6341887B2 (Direct) 1988-08-19

Family

ID=19829436

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13248878A Granted JPS5480404A (en) 1977-10-29 1978-10-27 High concentrated pharmaceutical preparation of steroid and production thereof

Country Status (10)

Country Link
US (1) US4212863A (Direct)
EP (1) EP0001851B1 (Direct)
JP (1) JPS5480404A (Direct)
AU (1) AU523752B2 (Direct)
CH (1) CH643738A5 (Direct)
DE (1) DE2861320D1 (Direct)
DK (1) DK152721C (Direct)
FI (1) FI67298C (Direct)
NL (1) NL7711916A (Direct)
NZ (1) NZ188755A (Direct)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0695177T3 (da) * 1993-04-20 1998-09-28 Hexal Ag Plaster indeholdende aktivt stof
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
US6703398B2 (en) * 2001-11-26 2004-03-09 Oliver Yoa-Pu Hu Orally administered analgesic compositions containing nalbuphine
EP1469860A4 (en) * 2002-01-24 2005-09-07 Yissum Res Dev Co ANTICANCER COMBINATION AND USE THEREOF
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
GB0807605D0 (en) 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025311A (en) * 1955-07-01 1962-03-13 Upjohn Co Hydrocortisone 21-beta beta-dimethyl glutarate and derivatives thereof
US2791609A (en) * 1956-09-27 1957-05-07 Murray A Kaplan Tetracycline metallo-phosphate complexes and method preparation
US3085939A (en) * 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
DE1492034A1 (de) * 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
JPS4916422B1 (Direct) * 1966-05-09 1974-04-22
US3636195A (en) * 1968-09-10 1972-01-18 Borden Inc Growth stimulating animal feeds
DE2240187A1 (de) * 1972-08-16 1974-02-21 Jereb Franz Dr Albin Salbe
GB1453239A (en) * 1974-04-30 1976-10-20 Ahrens G W Vitamin e active product and a method of preparing same

Also Published As

Publication number Publication date
NL7711916A (nl) 1979-05-02
DE2861320D1 (en) 1982-01-14
EP0001851B1 (en) 1981-11-11
DK480178A (da) 1979-04-30
AU4115878A (en) 1980-05-08
US4212863A (en) 1980-07-15
FI67298B (fi) 1984-11-30
EP0001851A1 (en) 1979-05-16
DK152721C (da) 1988-09-26
NZ188755A (en) 1981-02-11
FI67298C (fi) 1985-03-11
JPS5480404A (en) 1979-06-27
DK152721B (da) 1988-05-02
FI783249A7 (fi) 1979-04-30
CH643738A5 (en) 1984-06-29
AU523752B2 (en) 1982-08-12

Similar Documents

Publication Publication Date Title
US3164520A (en) Injectable steroid compositions containing at least 75% benzyl benzoate
KR100802366B1 (ko) 풀베스트란트 제제
US3800038A (en) Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier
US4147783A (en) Oral pharmaceutical preparation
US8338395B2 (en) Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
EP1295600B1 (de) Arzneimittel auf Basis von Gestagenen zur dermalen Anwendung enthaltend Ascorbinsäure sowie deren Salze
US4071623A (en) Pharmaceutical preparation adapted for oral administration
US4220599A (en) Oral pharmaceutical preparation having androgenic activity
US4083973A (en) Pharmaceutical preparation adapted for oral administration
US4098802A (en) Oral pharmaceutical preparation having androgenic activity
JP4845320B2 (ja) （７α，１１β）−ジメチル−１７β−ヒドロキシ−４−エストレン−３−オンの４−Ｎ−ブチルシクロヘキサン酸エステル及びウンデカン酸エステルの製造方法及びそれらの医学用途
JPS6341887B2 (Direct)
JP2002518514A (ja) テストステロン誘導体
US3423507A (en) Method of treating benign prostratic hypertrophy
KR890000907B1 (ko) 안정한 현탁액 제조용 고체 약물 제형의 제조방법
DD143077A5 (de) Verfahren zur herstellung von 1,3-dibenzoesaeureestern des 17alpha-ethinyl-7alpha-methyl-1,3,5(10)-oestratrien-1,3,17beta-triols
US3900561A (en) Pharmaceutical compositions
JPH0466847B2 (Direct)
US20030149008A1 (en) Hormonal implants treatment of the breast cancer
JPS61289096A (ja) ジヒドロテストステロン・ヘプタノエ−ト、その合成および使用方法
RU2322986C2 (ru) Применение новых сложных эфиров этоногестрела
US4794119A (en) Aqueous crystalline suspension of steroid glycoesters
US3284303A (en) Orally active progesterone compositions
CN111281877A (zh) 神经活性类固醇的新制剂
Sklow Prolongation of sex hormone effects by adsorption on powdered carbon